Nanoimmunotech is a Spanish company in the Nanobiotechnology sector, founded in August 2009, recognized as EIBT (Technologically Innovative Company) and Spin-off of form the Universities of Vigo and Zaragoza. It is the first European company dedicated to the biological and physico-chemical characterization and functionalization of nanoparticles (conjugation with different molecules such as nucleid acids, enzimes, antibodies, carbohydrates, peptides) and production of specific monoclonal antibodies (on demand).
Specialized in the production of optical coatings for high quality optics in industry and science: Mirrors and filters for high power lasers, steep and narrowband filters for analysis and communications and group-velocity compensating mirrors for ultrashortpulse lasers are some of our prominent products.
NanoLight Technologies is a division of Prolume Ltd., a biotechnology company developing broad applications of natural, light-emitting marine proteins, or marine bioluminescence. The NanoLight division is focused on becoming the leader in high-value reagent & reporter systems for new product development in the pharmaceutical, agrichemical, and research products industries.
Nanologica engineers nanoporous materials for use in a range of industries, from pharmaceuticals to petrochemicals. Their patented technique enables them to create structures that have novel properties and functions based on their size, shape or composition that boost efficiency and lower manufacturing costs.
Specializes in the production of nanomaterials (nanoparticles and nanopowders) having complex composition and exacting particle size and particle size distribution and tailored surface characteristics.
The company's mission is to enable their customers to evaluate and understand the mechanical performance of their materials on the micro- and nano-scales. With field experts in nanomechanical testing, data acquisition, system integration, and software development on their staff, tehy are well positioned to provide you with the most accurate results along with leading edge characterization.
NanoMedical Systems (NMS) is a startup company, which will commercialize the patented research of Dr. Mauro Ferrari at the University of Texas Health Science Center in Houston, a sponsored research site and a source of licensed IP for NMS. The company's Personalized Molecular Drug-delivery System (PMDS) is a small drug delivery device that is implanted subcutaneously (just under the skin) for slow and consistent release of a therapeutic agent over many weeks or months. A nanochannel delivery system (nDS) embodied on a silicon chip regulates the flow of therapeutic molecules.